Results 201 to 210 of about 404,095 (346)

A Relationship between Birch Pollen Counts and Meteorological Factors in Sapporo

open access: diamond, 2014
Hideaki Shirasaki   +6 more
openalex   +2 more sources

Fluorescent carbon dots from birch leaves for sustainable electroluminescent devices

open access: hybrid, 2023
Shi Tang   +10 more
openalex   +2 more sources

Molecular IgE Reactivity Profiling With Micro‐Arrayed Allergens Reveals Distinct Interregional Patterns of Sensitization and a Hypoallergenic Region in Türkiye

open access: yesAllergy, EarlyView.
A prospective, systematic and cross‐sectional population study was performed involving 1000 adult subjects from five centers representing different climatic areas of Türkiye (Turkey). Molecular IgE profiling demonstrated substantial interregional variation and identified a hypoallergenic region in the easternmost area with a continental climate.
Alp Kazancioglu   +22 more
wiley   +1 more source

Birch Pollen-Related Food Allergy: Occasionally Severe, Yet Home-Based Oral Food Challenges Are Safe. [PDF]

open access: yesClin Exp Allergy
Kallen EJJ   +6 more
europepmc   +1 more source

Influence of Biomass Pretreatment Process Time on Furfural Extraction from Birch Wood

open access: diamond, 2013
Prans Brazdausks   +3 more
openalex   +1 more source

Major Cat Allergen Fel d 4: Structure and Identification of a Cross‐Reactive IgE‐Epitope‐Containing Area

open access: yesAllergy, EarlyView.
This study reports the three‐dimensional structure of an important cat allergen, Fel d 4, that shares high homology with Equ c 1 (i.e., major horse allergen) and Can f 6 (i.e., dog allergen). The C‐terminal region of the Fel d 4 contains a major IgE‐reactive epitope.
Nikolina Todorović   +14 more
wiley   +1 more source

Emergent reactance induced by the deformation of a current-driven skyrmion lattice. [PDF]

open access: yesNat Commun
Littlehales MT   +8 more
europepmc   +1 more source

Long‐Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations

open access: yesAllergy, EarlyView.
LAR patients who respond to AIT during the first year and are treated for two more years continue improving (less symptoms and medication intake) during the following seven years. AIT prevents the onset of asthma and allergic sensitizations in responder LAR individuals during the seven years following discontinuation.
Almudena Testera‐Montes   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy